Abstract

Schizophrenic disorders, of which at least five separate kinds are now recognised, remain difficult to diagnose and still harder to treat. This second volume reviews the most important work published in the last year, with expert comment and analysis from two of the leading authorities in the field. The editors review the latest advances in our understanding of the biochemical basis of the disease, its detection and diagnosis, and its relationship to other co-existent mental illness. There is up-to-date coverage of psychopharmacological agents and expert comment on recent advances in neurological aspects. In addition, this volume also includes discussion of cognitive and negative symptoms therapies, and psychosocial treatments. The Year in Schizophrenia enables the reader to keep up to date with the therapeutic options available, and maintain a better informed perspective on current opinion. It should find a place in the office of every doctor involved in the study and treatment of this complex and challenging disorder.